vimarsana.com
5
6
7
8
9
10
11
Latest Breaking News On - Graham herring - Page 4 : vimarsana.com
GSTechnologies : Directorate Change | MarketScreener
GSTechnologies Limited , the fintech company, announces that Chong Loong Fatt Garies , Non-executive Director, has resigned from the Board of the Company with immediate effect in order. | June 16, 2023
Tim-metcalfe-graham
Simon-barton-thomas-jackson
Chong-loong-fatt
Douglas-crippen
Gstechnologies-limited
Board-of-the-company
Chong-loong-fatt-garies
Non-executive-director
Graham-herring
Gstechnologies-ltd-stock-exchange
News
Information
Investegate |Boku Inc Announcements | Boku Inc: Total Voting Rights and Share Capital
Investegate announcements from Boku Inc, Total Voting Rights and Share Capital
France
Vietnam
Republic-of
Japan
Brazil
Spain
China
Singapore
Taiwan
Germany
United-kingdom
India
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants ...
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants .
United-states
United-kingdom
London
City-of
Tim-metcalfe-graham
Matthew-chandler-rob-patrick
Company-new-ordinary
European-union-withdrawal
Financial-conduct-authority
Edison-group-us-investor-relations
Advisory-limited-financial
Biodexa-pharmaceuticals
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants ...
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants .
United-kingdom
United-states
London
City-of
Matthew-chandler-rob-patrick
Tim-metcalfe-graham
Strand-hanson-limited-nominated-adviser
Edison-group-us-investor-relations
Company-new-ordinary
News-network
Financial-conduct-authority
Biodexa-pharmaceuticals
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants ...
Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants .
London
City-of
United-kingdom
United-states
Tim-metcalfe-graham
Matthew-chandler-rob-patrick
Nasdaq
London-stock-exchange
Biodexa-pharmaceuticals
Advisory-limited-financial
Edison-group-us-investor-relations
Financial-conduct-authority
vimarsana © 2020. All Rights Reserved.